Genenta Science S.p.A. (GNTA) annual balance sheet — 7-year assets, liabilities & equity history
| Total Current Assets | 29.98M | 14.47M | 21.26M | 31.72M | 38.76M | 16.53M | 20.6M |
| Cash & Short-Term Investments | 28.15M | 12.66M | 18.78M | 29.79M | 37.24M | 15.47M | 20.14M |
| Cash Only | 5.53M | 4.58M | 3.69M | 29.79M | 37.24M | 15.47M | 20.14M |
| Short-Term Investments | 22.62M | 8.08M | 15.08M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.29M | 1.45M | 2M | 1.56M | 1.42M | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 144.69K | 76.26K | 27.67K | -163.49K |
| Days Inventory Outstanding | - | - | - | 8.81K | 5.46K | 5.71K | - |
| Other Current Assets | 337.44K | 210.83K | 64.66K | 115.86K | 3.74K | 1.01M | 593.08K |
| Total Non-Current Assets | 1.91M | 351.02K | 1.09M | 1.72M | 1.27M | 967.94K | 748.68K |
| Property, Plant & Equipment | 22.46K | 42.92K | 57.03K | 111.64K | 23.09K | 18.97K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 87.8K | 53.14K | 88 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.89M | 220.29K | 980.71K | 1.6M | 1.24M | 948.97K | 748.68K |
| Total Assets | 31.89M | 14.82M | 22.35M | 33.44M | 40.03M | 17.5M | 21.35M |
| Asset Turnover | - | - | - | - | - | - | - |
| Asset Growth % | 115.12% | -33.66% | -33.17% | -16.46% | 128.7% | -18.02% | - |
| Total Current Liabilities | 2.12M | 2.1M | 1.74M | 2.18M | 1.14M | 2.33M | 2.49M |
| Accounts Payable | 1.51M | 317.83K | 294.98K | 1.19M | 189.87K | 555.01K | 572.44K |
| Days Payables Outstanding | 20.42K | 2.49K | 2.58K | 72.69K | 13.6K | 114.58K | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 119K | 324.36K | 255.06K | 297.88K | 100.72K | 53.24K | 48K |
| Current Ratio | 14.16x | 6.89x | 12.25x | 14.53x | 34.15x | 7.09x | 8.29x |
| Quick Ratio | 14.16x | 6.89x | 12.25x | 14.46x | 34.08x | 7.07x | 8.35x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.93M | 228.93K | 179.25K | 116.18K | 30.62K | 17.39K | 11.33K |
| Long-Term Debt | 7.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 1.2K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 327.79K | 227.72K | 179.25K | 116.18K | 30.62K | 17.39K | 11.33K |
| Total Liabilities | 10.05M | 2.33M | 1.91M | 2.3M | 1.17M | 2.35M | 2.5M |
| Total Debt | 7.6M | 14.6K | 0 | 0 | 0 | 0 | 0 |
| Net Debt | 2.08M | -4.57M | -3.69M | -29.79M | -37.24M | -15.47M | -20.14M |
| Debt / Equity | 0.35x | 0.00x | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | -15.32x | - | - | - | - | - | - |
| Total Equity | 21.84M | 12.5M | 20.43M | 31.14M | 38.86M | 15.15M | 18.85M |
| Equity Growth % | 74.79% | -38.84% | -34.38% | -19.87% | 156.49% | -19.63% | - |
| Book Value per Share | 1.11 | 0.68 | 1.12 | 1.71 | 2.13 | 0.84 | 1.04 |
| Total Shareholders' Equity | 21.84M | 12.5M | 20.43M | 31.14M | 38.86M | 15.15M | 18.85M |
| Common Stock | 84.26M | 68.46M | 67.34M | 66.6M | 65.88M | 37.06K | 36.05K |
| Retained Earnings | -62.59M | -56.06M | -47.14M | -35.47M | -27.02M | -21.49M | -15.9M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 166.51K | 88.95K | 231.14K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying GNTA stock.
As of 2025, Genenta Science S.p.A. (GNTA) had total assets of $31.9M including $30.0M in current assets.
Genenta Science S.p.A. (GNTA) carries total debt of $7.6M, offset by $28.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Genenta Science S.p.A. (GNTA) has total shareholders' equity (book value) of $21.8M ($1.11 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Genenta Science S.p.A. (GNTA) reported a current ratio of 14.16x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.